CDC vs. ELCV

Last updated Jun 4, 2026

CDC (VictoryShares US EQ Income Enhanced Volatility Wtd ETF) and ELCV (Eventide High Dividend ETF) are both Large Cap Value Equities funds. CDC is passively managed, while ELCV is actively managed. Over the past year, CDC returned 18.16% vs 30.91% for ELCV. A 0.70 correlation means they provide meaningful diversification when combined. CDC charges 0.37%/yr vs 0.49%/yr for ELCV.

Performance

CDC vs. ELCV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) and Eventide High Dividend ETF (ELCV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CDC achieves a 10.57% return, which is significantly lower than ELCV's 21.38% return.

CDC

• 1D: -0.57%
• 1M: -0.39%
• YTD: 10.57%
• 6M: 10.29%
• 1Y: 18.16%
• 3Y*: 11.97%
• 5Y*: 5.08%
• 10Y*: 10.03%

ELCV

• 1D: 0.48%
• 1M: 4.35%
• YTD: 21.38%
• 6M: 20.08%
• 1Y: 30.91%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CDC vs. ELCV - Yearly Performance Comparison

	2026 (YTD)	2025	2024
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF	10.57%	8.96%	-2.70%
ELCV Eventide High Dividend ETF	21.38%	9.96%	-1.81%

Correlation

The correlation between CDC and ELCV is 0.67, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.67
Correlation (All Time) Calculated using the full available price history since Oct 2, 2024	0.70

The correlation between CDC and ELCV has been stable across timeframes, ranging from 0.67 to 0.70 - a consistent structural relationship.

Return for Risk

CDC vs. ELCV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CDC

CDC Risk / Return Rank: 58
CDC Sharpe Ratio Rank: 54
CDC Sortino Ratio Rank: 58
CDC Omega Ratio Rank: 50
CDC Calmar Ratio Rank: 65
CDC Martin Ratio Rank: 63

ELCV

ELCV Risk / Return Rank: 86
ELCV Sharpe Ratio Rank: 83
ELCV Sortino Ratio Rank: 82
ELCV Omega Ratio Rank: 79
ELCV Calmar Ratio Rank: 92
ELCV Martin Ratio Rank: 91

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CDC vs. ELCV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) and Eventide High Dividend ETF (ELCV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CDC	ELCV	Difference
Sharpe ratio: Return per unit of total volatility	1.87	2.71	-0.84
Sortino ratio: Return per unit of downside risk	2.78	3.70	-0.92
Omega ratio: Gain probability vs. loss probability	1.32	1.48	-0.16
Calmar ratio: Return relative to maximum drawdown	3.22	6.15	-2.93
Martin ratio: Return relative to average drawdown	11.37	21.81	-10.45
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CDC vs. ELCV - Sharpe Ratio Comparison

The current CDC Sharpe Ratio is 1.87, which is lower than the ELCV Sharpe Ratio of 2.71. The chart below compares the historical Sharpe Ratios of CDC and ELCV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CDC	ELCV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.87	2.71	-0.84
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.41	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.76	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.74	1.15	-0.41

Drawdowns

CDC vs. ELCV - Drawdown Comparison

The maximum CDC drawdown since its inception was -21.37%, which is greater than ELCV's maximum drawdown of -18.38%. Use the drawdown chart below to compare losses from any high point for CDC and ELCV.

Drawdown Indicators

	CDC	ELCV	Difference
Max Drawdown Largest peak-to-trough decline	-21.37%	-18.38%	-2.99%
Max Drawdown (1Y) Largest decline over 1 year	-5.67%	-5.05%	-0.62%
Max Drawdown (3Y) Largest decline over 3 years	-12.70%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-21.37%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-21.37%	—	—
Current Drawdown Current decline from peak	-2.20%	0.00%	-2.20%
Average Drawdown Average peak-to-trough decline	-5.09%	-3.75%	-1.34%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.60%	1.43%	+0.17%

Volatility

CDC vs. ELCV - Volatility Comparison

The current volatility for VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) is 2.66%, while Eventide High Dividend ETF (ELCV) has a volatility of 3.61%. This indicates that CDC experiences smaller price fluctuations and is considered to be less risky than ELCV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CDC	ELCV	Difference
Volatility (1M) Calculated over the trailing 1-month period	2.66%	3.61%	-0.95%
Volatility (6M) Calculated over the trailing 6-month period	6.84%	8.75%	-1.91%
Volatility (1Y) Calculated over the trailing 1-year period	9.77%	11.47%	-1.70%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	12.54%	15.38%	-2.84%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	13.21%	15.38%	-2.17%

CDC vs. ELCV - Expense Ratio Comparison

CDC has a 0.37% expense ratio, which is lower than ELCV's 0.49% expense ratio.

Dividends

CDC vs. ELCV - Dividend Comparison

CDC's dividend yield for the trailing twelve months is around 3.18%, more than ELCV's 1.76% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF	3.18%	3.36%	3.32%	4.24%	3.48%	2.65%	2.48%	3.04%	3.37%	2.81%	2.99%	3.17%
ELCV Eventide High Dividend ETF	1.76%	2.34%	0.29%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both CDC and ELCV in my portfolio?

CDC and ELCV have a correlation of 0.67, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CDC or ELCV?

ELCV has higher volatility (3.61%) compared to CDC (2.66%). In terms of maximum drawdown, CDC dropped -21.37% vs ELCV's -18.38%.

Which ETF is better, CDC or ELCV?

On 1-year performance, ELCV leads with 30.91% vs 18.16% for CDC. On fees, CDC is cheaper at 0.37% per year. On volatility, CDC has been the lower-risk option at 2.66%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, CDC or ELCV?

Over the 1-year period, ELCV has performed better with a 30.91% return vs 18.16%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, CDC or ELCV?

CDC is cheaper with a 0.37% expense ratio, compared with 0.49% for ELCV.

Which ETF pays a higher dividend yield, CDC or ELCV?

CDC has the higher dividend yield at 3.18%, compared with 1.76% for ELCV.

What is the main difference between CDC and ELCV?

They also come from different issuers: Crestview and Eventide. Their fees differ too: 0.37% for CDC and 0.49% for ELCV.

Which has better risk-adjusted returns?

ELCV currently has the higher Sharpe Ratio (2.71 vs 1.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.